Literature DB >> 11466248

Reduced incidence of retinopathy of prematurity.

E Rowlands1, A C Ionides, S Chinn, H Mackinnon, C C Davey.   

Abstract

AIM: To audit the prevalence of retinopathy of prematurity (ROP) in a level 2 status neonatal unit.
METHODS: Data were collected prospectively over 9 years from September 1989 to September 1998. Preterm infants were examined according to the Royal College of Ophthalmologists' guidelines and retinopathy graded following the International Classification of ROP. ROP 3-5 was analysed using logistic regression in relation to time, and to gestational age and birth weight.
RESULTS: 383 babies were examined. Mean gestational age fell over the 9 year period (p=0.051) as did mean birth weight (p<0.001). There was a decrease in the number of infants with ROP grades 3-5 over the 9 years (p=0.045 and, when adjusted for gestational age and birth weight, the decrease in ROP 3-5 was significant (p=0.03).
CONCLUSIONS: This study found a significant reduction in the incidence of ROP during the 9 years of the study period, despite a decrease in mean gestational age of and birth weight. The reduced incidence of ROP is attributed to improvements in ventilation techniques and overall care of the neonate, in particular the use of prenatal steroids and surfactant.

Entities:  

Mesh:

Year:  2001        PMID: 11466248      PMCID: PMC1724080          DOI: 10.1136/bjo.85.8.933

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight.

Authors:  J Vyas; D Field; E S Draper; G Woodruff; A R Fielder; J Thompson; N J Shaw; D Clark; R Gregson; J Burke; G Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Incidence and severity of retinopathy of prematurity.

Authors:  J D Reynolds; R J Hardy; E A Palmer
Journal:  J AAPOS       Date:  1999-10       Impact factor: 1.220

3.  Epidemiology of retinopathy of prematurity.

Authors:  Y K Ng; A R Fielder; D E Shaw; M I Levene
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

Review 4.  Retinopathy of prematurity.

Authors:  I Ben Sira; I Nissenkorn; I Kremer
Journal:  Surv Ophthalmol       Date:  1988 Jul-Aug       Impact factor: 6.048

5.  Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity.

Authors:  P H Valentine; J C Jackson; R E Kalina; D E Woodrum
Journal:  Pediatrics       Date:  1989-09       Impact factor: 7.124

6.  Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic.

Authors:  D L Gibson; S B Sheps; S H Uh; M T Schechter; A Q McCormick
Journal:  Pediatrics       Date:  1990-09       Impact factor: 7.124

7.  Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county.

Authors:  H C Fledelius; H Dahl
Journal:  Acta Ophthalmol Scand       Date:  2000-06

8.  Retinopathy of prematurity: a new epidemic?

Authors:  D L Gibson; S B Sheps; M T Schechter; S Wiggins; A Q McCormick
Journal:  Pediatrics       Date:  1989-04       Impact factor: 7.124

9.  Incidence of retinopathy of prematurity in a tertiary newborn intensive care unit.

Authors:  P B Campbell; M J Bull; F D Ellis; C Q Bryson; J A Lemons; R L Schreiner
Journal:  Arch Ophthalmol       Date:  1983-11

10.  Risk factors in retrolental fibroplasia.

Authors:  T R Gunn; J Easdown; E W Outerbridge; J V Aranda
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

View more
  10 in total

Review 1.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 2.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

3.  The effect of early treatment at the initial stage 3 moderate phase of retinopathy of prematurity on severe retinal changes.

Authors:  Yoshikazu Hatsukawa; Nami Ueki; Tomoko Yamagishi; Hiroyuki Kitajima
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

4.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Incidence of ROP in two consecutive Swedish population based studies.

Authors:  E Larsson; B Carle-Petrelius; G Cernerud; L Ots; A Wallin; G Holmström
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors.

Authors:  Vivek B Wani; Niranjan Kumar; Khalid Sabti; Seemant Raizada; Nabeel Rashwan; Mumtaz M Shukkur; Mohammed Harbi
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

7.  Ophthalmic impairment at 7 years of age in children born very preterm.

Authors:  R W I Cooke; L Foulder-Hughes; D Newsham; D Clarke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

8.  Retinopathy of Prematurity: Advances in the Screening and Treatment of Retinopathy of Prematurity Using a Single Center Approach.

Authors:  Audina M Berrocal; Kenneth C Fan; Hasenin Al-Khersan; Catherin I Negron; Timothy Murray
Journal:  Am J Ophthalmol       Date:  2021-07-21       Impact factor: 5.258

9.  Retinopathy of prematurity in port harcourt, Nigeria.

Authors:  Adedayo O Adio; Rosemary O Ugwu; Chidi G Nwokocha; Augusta U Eneh
Journal:  ISRN Ophthalmol       Date:  2014-02-04

10.  Influence of subretinal fluid in advanced stage retinopathy of prematurity on proangiogenic response and cell proliferation.

Authors:  Jie Ma; Manisha Mehta; Godfrey Lam; Desireé Cyr; Tat Fong Ng; Tatsuo Hirose; Khaled A Tawansy; Andrew W Taylor; Kameran Lashkari
Journal:  Mol Vis       Date:  2014-06-21       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.